Bedel Financial Consulting, Inc. Neogenomics Inc Transaction History
Bedel Financial Consulting, Inc.
- $645 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
281Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$301 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$216 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$147 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$104 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$95.3 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.91B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...